Fierce Pharma
MAY 23, 2024
Over the last four years, with President Joe Biden milking a popular cause as an opponent of Big Pharma drug pricing, the industry has rarely seen good news coming from the White House. | Over the last four years, with President Joe Biden milking a popular cause as an opponent of Big Pharma's pricing, the industry has rarely seen good news coming from the White House.
MedCity News
MAY 23, 2024
As the healthcare industry slowly moves toward value-based care, healthcare companies are thinking about taking on risk. During a panel at MedCity News’ INVEST conference, healthcare leaders shared some key ideas about how the industry is embracing risk in its contracts. The post Is the Healthcare Industry Embracing Risk in Its Contracts? appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
MAY 23, 2024
Over the years, melanoma has become a popular testing ground for researchers to explore new immuno-oncology approaches. | With prior approvals in melanoma, Bristol Myers Squibb and Iovance are now showcasing early clinical data for their novel combinations in small first-line melanoma trials.
MedCity News
MAY 23, 2024
Fem Therapeutics won the audience choice award in the Canadian PItch contest at MedCity INVEST in Chicago this week. It competed with Reach Orthopaedics , PragmaClin Research, and OPTT Health. The post Canadian Women’s Health Medtech Startup Wins Over Audience at MedCity INVEST appeared first on MedCity News.
Fierce Pharma
MAY 23, 2024
As Johnson & Johnson sorts through a mountain of litigation claiming its talcum-based powders caused users to develop cancers, the company has now been slapped with a related but different | Women represented by six law firms who previously filed lawsuits against J&J over talc claims have filed a proposed class action lawsuit in U.S. federal court in New Jersey.
Pharmaceutical Commerce
MAY 23, 2024
The deal features felzartamab, an investigational anti-CD38 monoclonal antibody, whose clinical outcomes have shown potential to tackle various immune-mediated diseases.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaTimes
MAY 23, 2024
High-grade gliomas are rare, malignant tumours which account for up to 12% of all childhood brain tumours
Pharmaceutical Technology
MAY 23, 2024
AstraZeneca has entered into a worldwide licence and option agreement with Nona Biosciences for a preclinical monoclonal antibody.
MedCity News
MAY 23, 2024
Hims & Hers is now providing access to compounded GLP-1s. Patients also receive unlimited medical consultations with a licensed provider. The post Hims & Hers Offers Access to GLP-1s Starting At $199 A Month appeared first on MedCity News.
pharmaphorum
MAY 23, 2024
Cytokinetics has been a top biotech takeover candidate for some time, thanks to blockbuster speculation about its lead drug aficamten, but a $1 billion-plus set of financing deals shows it is prepared to go to market on its own.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
MAY 23, 2024
The impact of personal health literacy on seniors The post Unlocking Better Health: The Role of Personal Health Literacy in Medicare Advantage Enrollment appeared first on MedCity News.
pharmaphorum
MAY 23, 2024
Novo Nordisk’s second facility fire in a week is under control, although the office in Bagsvaerd affected by the latest blaze isn’t expected to be salvageable.
Pharmaceutical Technology
MAY 23, 2024
Merck KGaA’s MilliporeSigma has entered a definitive agreement for the acquisition of Mirus Bio in a deal totaling $600m (€500m).
pharmaphorum
MAY 23, 2024
Merck KGaA has agreed to a $600m deal to buy Mirus Bio, a specialist in transfection reagents used in the production of cell and gene therapies.
Pharmaceutical Commerce
MAY 23, 2024
The CDMO will run the active pharmaceutical ingredient pilot plant in Sandwich, UK, along with development laboratories.
European Pharmaceutical Review
MAY 23, 2024
A paper has reported a multi-material ink-jet 3D printing (MM-IJ3DP)-based method that could enable tailored drug release profiles of personalised pharmaceutical tablets during manufacturing. While biocompatible water-soluble polymers as excipients, have “been recently explored to produce gels [they have not been investigated] as a water-soluble excipient”, according to the paper.
pharmaphorum
MAY 23, 2024
China’s Asymchem Laboratories has agreed to take over the operation of a Pfizer manufacturing facility in Sandwich, UK, saving dozens of jobs.
MedCity News
MAY 23, 2024
GLP-1 agonists are transforming the weight loss market. Experts weighed in on the changes they’re seeing, speaking in a panel discussion during the MedCity News INVEST Conference in Chicago. The post Navigating Opportunities and Challenges in the GLP-1 Drug Gold Rush appeared first on MedCity News.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
pharmaphorum
MAY 23, 2024
Biogen has expanded its specialty immunology pipeline with an agreement to buy Human Immunology Biosciences (HI-Bio) and its lead drug felzartamab, in trials for a range of diseases including IgA nephropathy (IgAN).
PharmaTimes
MAY 23, 2024
The partnership will provide six MRC clinical fellows with industry placement opportunities
PM360
MAY 23, 2024
Karin Hayes SVP, Analytics Products and Services OptimizeRx Innovation Data Connection to Fuel Patient Centricity Karin Hayes is a transformative leader who combines her strong pharmaceutical background with deep expertise in longitudinal healthcare data and advanced analytics to bring strategic data solutions to pharmaceutical marketing. As the industry navigates advanced analytics and machine learning, Karin stands out as a healthcare leader who turns numbers into insights.
pharmaphorum
MAY 23, 2024
What are the pros and cons of synthetic clinical trials? Get insights from podcast guests Web Sun and Tracy Mayne on the latest developments in this cutting-edge field.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
PM360
MAY 23, 2024
Tim Arendt Managing Director, Consulting Hot Iron Health, a Spectrum Science company Charging Into New Consulting Models Tim Arendt was once a firefighter. It’s why he’s not afraid to head in first. Tim rejects the status quo and changes how the industry operates. His focus on healthcare brands and their challenges is rooted in a passion for patients and positive patient outcomes.
Rep-Lite
MAY 23, 2024
When bright, enthusiastic new medical sales reps join your team, they’re eager to learn and full of potential. But in reality, they also face a mountain of information about the company, products, and the intricacies of medical sales. An effective onboarding program is the key that unlocks their potential and propels them towards success. Here at Rep-Lite , we’ve witnessed the transformative power of well-designed onboarding firsthand.
PharmExec
MAY 23, 2024
Approval for the Phase III protocol of LAE002 Plus LAE001 come as a result of posiive Phase II data, which showed promising benefits for metastatic castration-resistant prostate cancer (mCRPC) patients.
Pharmaceutical Technology
MAY 23, 2024
In this issue: Lula's progress plan for Brazil, tracking opioid lawsuit settlements in the US, the cell & gene therapy landscape in the US, the latest on ESG in pharma, and more.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Spotio
MAY 23, 2024
In a recent webinar hosted by SPOTIO, we delved into the secrets behind high-performing sales teams. Presented by Trey Gibson, CEO/Founder of SPOTIO, the session offered valuable insights from SPOTIO’s annual State of Field Sales study. If you missed it, don’t worry—we’ve summarized the key takeaways to help you transform your sales team’s performance.
PM360
MAY 23, 2024
Mike Edwards Executive Director, Marketing Strategy Malignant Hematology Novartis Never Settling for Strong, Only Stronger Chronic myeloid leukemia (CML) was a complacent treatment category in need of a disruptor. Enter Mike Edwards, who leads the SCEMBLIX brand team at Novartis. CML has been relatively well-controlled for more than a decade—to the point where some HCPs are so satisfied with their treatment options that they refer to it as the “good cancer.
Copyright Clearance Center
MAY 23, 2024
May 23, 2024 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, announces that the newest edition of The State of Scholarly Metadata report, which depicts the complexities and value of scholarly publishing metadata, will be made available at the 2024 Society for Scholarly Publishing (SSP) 46 th Annual Meeting 29-31 May at the Westin Boston Seaport District.
PM360
MAY 23, 2024
Alex Sophocles Vice-President, Experience imre The Benefits of Saying, “What If?” Alex is an integrated marketing strategist with over 13 years of experience leading consumer, healthcare, and medical brands to success. Using human-centered methodologies, he approaches business challenges by collaborating with patients and healthcare professionals to ensure business goals and customer values are aligned.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Expert insights. Personalized for you.
321 
Let's personalize your content